Three Researchers Granted Over $1 Million to De-Risk and Progress Preclinical Drug Candidates for Neurodegenerative Diseases
Inaugural funding through the Sprint to Lead program aims to translate scientific breakthroughs into therapeutic innovations FORT WORTH, Texas, Nov. 10, 20